Peroxisome proliferator-activated receptor g-mediated inhibition on hypoxia-triggered store-operated calcium entry a caveolin-1-dependent mechanism

American Journal of Respiratory Cell and Molecular Biology

Volumn 53, Issue 6, 2015, Pages 882-892

  Yang, Kai ^a,c   Lu, Wenju ^a,c   Jiang, Qian ^a,c   Yun, Xin ^a,c   Zhao, Mingming ^d   Jiang, Haiyang ^b   Wang, Jian ^a,c,d  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b People's Hospital of Inner Mongolia   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Caveolin 1; Peroxisome proliferator activated receptor g; Pulmonary arterial smooth muscle cells; Pulmonary hypertension; Store operated calcium entry

Indexed keywords

BETA TUBULIN; CALCIUM ION; CAVEOLIN 1; COMPLEMENTARY DNA; HISTONE H3; MANGANESE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA; BENZOPHENONE DERIVATIVE; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PROTEIN BINDING; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; HYPOXIA; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; GENE EXPRESSION; LYSOSOME; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE CELL; UPREGULATION; WISTAR RAT;

ANIMALS; BENZOPHENONES; CALCIUM SIGNALING; CAVEOLIN 1; CELL HYPOXIA; CELLS, CULTURED; GENE EXPRESSION; LYSOSOMES; MALE; MYOCYTES, SMOOTH MUSCLE; PPAR GAMMA; PROTEIN BINDING; PROTEOLYSIS; PULMONARY ARTERY; RATS, WISTAR; TYROSINE; UP-REGULATION;

EID: 84963805272     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2015-0002OC     Document Type: Article

References (56)

1. Shimoda LA, Laurie SS. Vascular remodeling in pulmonary hypertension. J Mol Med (Berl) 2013;91:297-309.
2. Shimoda LA, Laurie SS. HIF and pulmonary vascular responses to hypoxia. J Appl Physiol (1985) 2014;116:867-874.
3. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-1665.
4. Jernigan NL, Resta TC. Calcium homeostasis and sensitization in pulmonary arterial smooth muscle. Microcirculation 2014;21:259-271.
5. Wang J, Weigand L, Lu W, Sylvester JT, Semenza GL, Shimoda LA. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca21 in pulmonary arterial smooth muscle cells. Circ Res 2006;98:1528-1537.
6. Lin MJ, Leung GP, Zhang WM, Yang XR, Yip KP, Tse CM, Sham JS. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca21 channels in pulmonary arterial smooth muscle cells: A novel mechanism of hypoxic pulmonary hypertension. Circ Res 2004;95:496-505.
7. Wang J, Shimoda LA, Sylvester JT. Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 2004;286:L848-L858.
8. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, et al. International union of pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 2006;58:726-741.
9. Gong K, Xing D, Li P, Aksut B, Ambalavanan N, Yang Q, Nozell SE, Oparil S, Chen YF. Hypoxia induces downregulation of PPAR-g in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-b signaling. Am J Physiol Lung Cell Mol Physiol 2011;301:L899-L907.
10. Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, Gardai SJ, Wick M, Nemenoff RA, Geraci MW, Voelkel NF. Peroxisome proliferator-activated receptor gamma (PPARg) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 2003;92:1162-1169.
11. Wang J, Yang K, Xu L, Zhang Y, Lai N, Jiang H, Zhong N, Ran P, Lu W. Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARg axis. Am J Respir Cell Mol Biol 2013;49: 231-240.
12. Nisbet RE, Bland JM, Kleinhenz DJ, Mitchell PO, Walp ER, Sutliff RL, Hart CM. Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol 2010;42:482-490.
13. Wang Y, Lu W, Yang K, Zhang J, Jia J, Yun X, Tian L, Chen Y, Jiang Q, Zhang B, et al. Peroxisome proliferator-activated receptor gamma inhibits pulmonary hypertension targeting store-operated calcium entry. J Mol Med (Berl) 2015;93:327-342.
14. Kim EK, Lee JH, Oh YM, Lee YS, Lee SD. Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats. Respirology 2010;15:659-668.
15. Patel HH, Zhang S, Murray F, Suda RY, Head BP, Yokoyama U, Swaney JS, Niesman IR, Schermuly RT, Pullamsetti SS, et al. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J 2007;21:2970-2979.
16. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxiainducible factor 1alpha. J Clin Invest 1999;103:691-696.
17. Lu W, Wang J, Shimoda LA, Sylvester JT. Differences in STIM1 and TRPC expression in proximal and distal pulmonary arterial smooth muscle are associated with differences in Ca21 responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 2008; 295:L104-L113.
18. Wang J, Jiang Q, Wan L, Yang K, Zhang Y, Chen Y, Wang E, Lai N, Zhao L, Jiang H, et al. Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats. Am J Respir Cell Mol Biol 2013;48:125-134.
19. Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lindstrom MS, Bhat KP, Godfrey VL, Evan GI, Zhang Y. Targeted inactivation of Mdm2 ring finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 2007;12:355-366.
20. Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, Migneco G, Witkiewicz AK, Martinez- Cantarin MP, Flomenberg N, et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 2010;9:2423-2433.
21. Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, Lisanti MP. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 2012;7:423-467.
22. Burgermeister E, Tencer L, Liscovitch M. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene 2003;22:3888-3900.
23. Burgermeister E, Friedrich T, Hitkova I, Regel I, Einwachter H, Zimmermann W, Rocken C, Perren A, Wright MB, Schmid RM, et al. The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor gamma through spatial relocalization at helix 7 of its ligand-binding domain. Mol Cell Biol 2011;31:3497-3510.
24. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992;68:673-682.
25. Suzuki Y, Yamamura H, Ohya S, Imaizumi Y. Caveolin-1 facilitates the direct coupling between large conductance Ca21-activated K1 (BKCa) and CAV1.2 Ca21 channels and their clustering to regulate membrane excitability in vascular myocytes. J Biol Chem 2013;288: 36750-36761.
26. Isshiki M, Nishimoto M, Mizuno R, Fujita T. Fret-based sensor analysis reveals caveolae are spatially distinct Ca21 stores in endothelial cells. Cell Calcium 2013;54:395-403.
27. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB. Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 2003;285:L1179-L1183.
28. Isshiki M, Ying YS, Fujita T, Anderson RG. A molecular sensor detects signal transduction from caveolae in living cells. J Biol Chem 2002; 277:43389-43398.
29. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004;84:1341-1379.
30. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001;276:38121-38138.
31. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, Dalton N, Chu PH, Peterson K, Ross J Jr, Chien KR. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 2002;99:11375-11380.
32. Achcar RO, Demura Y, Rai PR, Taraseviciene-Stewart L, Kasper M, Voelkel NF, Cool CD. Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. Chest 2006;129: 696-705.
33. Mathew R. Cell-specific dual role of caveolin-1 in pulmonary hypertension. Pulm Med 2011;2011:573432.
34. Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB. Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 2004;110:1499-1506.
35. Murata T, Lin MI, Huang Y, Yu J, Bauer PM, Giordano FJ, Sessa WC. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 2007;204:2373-2382.
36. Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Circulation 2006;114:912-920.
37. Murata T, Sato K, Hori M, Ozaki H, Karaki H. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxiainduced pulmonary hypertension. J Biol Chem 2002;277: 44085-44092.
38. Li S, Couet J, Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveolin binding negatively regulates the auto-activation of src tyrosine kinases. J Biol Chem 1996;271:29182-29190.
39. Murata T, Lin MI, Stan RV, Bauer PM, Yu J, Sessa WC. Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. J Biol Chem 2007;282:16631-16643.
40. Zhao YY, Zhao YD, Mirza MK, Huang JH, Potula HH, Vogel SM, Brovkovych V, Yuan JX, Wharton J, Malik AB. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 2009;119:2009-2018.
41. Lockwich TP, Liu X, Singh BB, Jadlowiec J, Weiland S, Ambudkar IS. Assembly of TRP1 in a signaling complex associated with caveolinscaffolding lipid raft domains. J Biol Chem 2000;275:11934-11942.
42. Bergdahl A, Gomez MF, Dreja K, Xu SZ, Adner M, Beech DJ, Broman J, Hellstrand P, Sward K. Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca21 entry dependent on TRPC1. Circ Res 2003;93:839-847.
43. Brazer SC, Singh BB, Liu X, Swaim W, Ambudkar IS. Caveolin-1 contributes to assembly of store-operated Ca21 influx channels by regulating plasma membrane localization of TRPC1. J Biol Chem 2003;278:27208-27215.
44. Kwiatek AM, Minshall RD, Cool DR, Skidgel RA, Malik AB, Tiruppathi C. Caveolin-1 regulates store-operated Ca21 influx by binding of its scaffolding domain to transient receptor potential channel-1 in endothelial cells. Mol Pharmacol 2006;70:1174-1183.
45. Remillard CV, Yuan JX. Transient receptor potential channels and caveolin-1: good friends in tight spaces. Mol Pharmacol 2006;70: 1151-1154.
46. Pani B, Liu X, Bollimuntha S, Cheng KT, Niesman IR, Zheng C, Achen VR, Patel HH, Ambudkar IS, Singh BB. Impairment of TRPC1-stim1 channel assembly and AQP5 translocation compromise agoniststimulated fluid secretion in mice lacking caveolin1. J Cell Sci 2013; 126:667-675.
47. Xie L, Xue X, Taylor M, Ramakrishnan SK, Nagaoka K, Hao C, Gonzalez FJ, Shah YM. Hypoxia-inducible factor/MAZ-dependent induction of caveolin-1 regulates colon permeability through suppression of occludin, leading to hypoxia-induced inflammation. Mol Cell Biol 2014;34:3013-3023.
48. Wang Y, Roche O, Xu C, Moriyama EH, Heir P, Chung J, Roos FC, Chen Y, Finak G, Milosevic M, et al. Hypoxia promotes ligandindependent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci USA 2012;109:4892-4897.
49. Llaverias G, Vazquez-Carrera M, Sanchez RM, Noe V, Ciudad CJ, Laguna JC, Alegret M. Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. J Lipid Res 2004;45:2015-2024.
50. Tencer L, Burgermeister E, Ebert MP, Liscovitch M. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPREindependent mechanisms: The role of EGF receptor signaling and its effect on cancer cell drug resistance. Anticancer Res 2008;28: 895-906.
51. Chintharlapalli S, Papineni S, Safe S. 1, 1-Bis(39-indolyl)-1-(psubstituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARg-dependent and PPARg-independent pathways. Mol Cancer Ther 2006;5:1362-1370.
52. Chintharlapalli S, Papineni S, Baek SJ, Liu S, Safe S. 1, 1-Bis(39-indolyl)- 1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal antiinflammatory drug-activated gene-1. Mol Pharmacol 2005;68: 1782-1792.
53. Chintharlapalli S, Papineni S, Safe S. 1, 1-bis(39-indolyl)-1-(psubstitutedphenyl) methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gammaindependent pathways. Mol Pharmacol 2007;71:558-569.
54. Tian J, Smith A, Nechtman J, Podolsky R, Aggarwal S, SneadC, Kumar S, Elgaish M, Oishi P, Goerlach A, et al. Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension. Physiol Genomics 2009;40:48-60.
55. Gearing KL, Gottlicher M, Teboul M, Widmark E, Gustafsson JA. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci USA 1993;90:1440-1444.
56. Thiazolidinediones YJH. Thiazolidinediones. N Engl J Med 2004;351: 1106-1118.